ElsaLys Biotech's Series A Round

ElsaLys Biotech raised a round of funding on May 17, 2013.

ElsaLys Biotech is an R&D start-up positioned at the interface of academic research and the pharmaceutical industry. Its mission is to convert first-in-class therapeutic targets into exploitable drug …

Articles about ElsaLys Biotech's Series A Round: